NCT05044039 2026-02-02Duvelisib Following Chimeric Antigen Receptor T-Cell TherapyWashington University School of MedicinePhase 1 Active not recruiting42 enrolled
NCT02028039 2014-01-06IPI-145 in Relapsed Refractory Acute Lymphoblastic Leukemia (ALL)M.D. Anderson Cancer CenterPhase 2 Withdrawn